Demand and packaging issues behind MMR jab and misoprostol export ban

Global demand and packaging issues are among a raft of reasons why MMR vaccines, alogliptin with metformin and misoprostol cannot leave the UK, the DH has told C+D.

ExportBan.jpg
DH: Export ban aims to tackle ongoing shortages and minimise the impact on patients

Latest from News

More from Clinical